A2i Therapeutics Overview

  • Founded
  • 2020

Founded
  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Investors
  • 8

A2i Therapeutics General Information

Description

Developer of novel small-molecule immuno-oncology agents designed for the treatment of immuno-oncology diseases. The company's therapeutics are developed by leveraging an artificial intelligence platform in order to target a key protein involved in controlling the innate immune response and potentially a key immuno-oncology target, enabling healthcare professionals to optimally combat and treat serious diseases.

Contact Information

Website
www.a2i-tx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 2 Ilan Ramon
  • Building B, 3rd Floor
  • Ness Ziona 7403635
  • Israel
+972 00-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

A2i Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 18-Dec-2020 Completed Startup
1. Joint Venture 01-Nov-2020 Completed Startup
To view A2i Therapeutics’s complete valuation and funding history, request access »

A2i Therapeutics Executive Team (1)

Name Title Board Seat Contact Info
Oshik Segev Chief Scientific Officer
To view A2i Therapeutics’s complete executive team members history, request access »

A2i Therapeutics Board Members (2)

Name Representing Role Since
Kinneret Livnat Savitzky Ph.D FutuRx Board Member 000 0000
Lior Teitelbaum Self Board Member 000 0000
To view A2i Therapeutics’s complete board members history, request access »

A2i Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Israel Innovation Authority Government Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Leaps by Bayer Corporate Venture Capital Minority 000 0000 000000 0
OrbiMed PE/Buyout Minority 000 0000 000000 0
RMGLOBAL Healthcare Fund Management Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »